OakChart

Bio Green Med Solution Inc

BGMSIndustrials·Building Products & Equipment·Malaysia·Nano·NASD·Nov 11 • 3:59 PM ET

0.6702-0.1309 (-16.34%)
2026-11-12 02:23 CET
Market cap
4.44 USD m
Revenue, TTM
1.86 USD m
Net income, TTM
-13.31 USD m
Free cash flow, TTM
-1.10 USD m
EPS diluted, TTM
-3.63
P/E
-
Compare

Price

BGMS against its 20, 50 and 200-day averages
2050200earnings
1.002.003.0052.7M105.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BGMSclose 0.6720-day 0.8950-day 0.90200-day 0.940.6752w high

76.1% under the 52-week high of 2.80 on 5 Jun 2026. 52-week low 0.57 on 26 Jun 2026. Last 15 sessions, 64.7% high to low

Volume 1.66× normal · the line is the 50-bar volume average

Profile

BGMS
52-week range, 4% of the way up
0.572.80

Bio Green Med Solution, Inc. which engages in the supply and trading of protective and fire safety equipment to commercial, industrial, healthcare, and residential sectors. Its products include fire extinguishers, foam system, fire-resistant doors, and personal protective equipment. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on January 5, 1996 and is headquartered in Kuala Lumpur, Malaysia.

IPOMar 16, 2004
Beta-0.46
ATR, 14d0.08
Rel volume1.66
Short float0.56%
Insider own26.76%
Inst own1.48%

Snapshot

6 groups

Valuation

Index-
Market Cap4.44M
Enterprise Value0.65M
Income-13.31M
Sales1.86M
Book/sh1.08
Cash/sh0.57
Dividend Est.-
Dividend TTM-
Dividend Ex-DateApr 29, 2025
Dividend Gr. 3/5Y- -
Payout-
Employees-
IPOMar 16, 2004

Ratios

P/E-
Forward P/E-
PEG-
P/S2.39
P/B0.62
P/C1.17
P/FCF-
EV/EBITDA-
EV/Sales0.35
Quick Ratio7.22
Current Ratio8.63
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-3.63
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y90.62% 77.93%
Sales past 3/5Y- -
EPS Y/Y TTM98.80%
Sales Y/Y TTM18510.00%
EPS Q/Q91.01%
Sales Q/Q-
EarningsMay 14 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own26.76%
Insider Trans0.00%
Inst Own1.48%
Inst Trans8.10%
ROA-215.98%
ROE-245.28%
ROIC-184.83%
Gross Margin19.29%
Oper. Margin-147.13%
Profit Margin-715.48%
SMA20-24.51%
SMA50-25.23%
SMA200-28.96%
Trades-

Technical

Shs Outstand6.62M
Shs Float4.85M
Short Float0.56%
Short Ratio0.38
Short Interest0.03M
52W High2.80 -76.06%
52W Low0.57 18.33%
Volatility11.04% 8.16%
ATR (14)0.08
RSI (14)30.24
Beta-0.46
Rel Volume1.66
Avg Volume70.90K
Volume117,827

Performance

Perf Week-25.13%
Perf Month-27.14%
Perf Quarter-27.55%
Perf Half Y-32.98%
Perf YTD-54.72%
Perf Year-52.13%
Perf 3Y-99.97%
Perf 5Y-100.00%
Perf 10Y-100.00%
Recom3.00
Target Price240.00
Prev Close0.80
Price0.67
Change %-16.34%

Analyst ratings

latest 10 of 15
DateActionAnalystRating changeTargetImplied
Jul 18, 2022ResumedOOppenheimerOutperform$17+2,436.6%
Apr 27, 2020ResumedRROTH CapitalBuy$24+3,481.0%
Sep 07, 2018InitiatedLLadenburg ThalmannBuy
Oct 16, 2015InitiatedHH.C. WainwrightBuy$5+646.0%
Feb 04, 2010InitiatedRRoth CapitalBuy$7+944.5%
Oct 28, 2009InitiatedMMerrimanBuy
Aug 12, 2008InitiatedPPiper JaffrayBuy$5+646.0%
Mar 12, 2008ReiteratedNNeedham & CoBuy$12 → $7+944.5%
Mar 12, 2008ReiteratedCCollins StewartBuy$12 → $13+1,839.7%
Mar 12, 2008ReiteratedCCantor FitzgeraldBuy$10.50 → $9+1,242.9%

Peers

Mkt cap
TickerCompanyMkt cap
DCMDeFi Capital Markets Inc9.78M
JLHLJulong Holding Ltd115.39M
APTAlpha Pro Tech Ltd63.89M
ILAGIntelligent Living Application Group Inc3.60M
APGAPi Group Corp18.90B
NSSCNAPCO Security Technologies Inc1.10B
PPIHPerma-Pipe International Holdings Inc237.41M
MSAMSA Safety Inc6.79B
CSTECaesarstone Ltd44.27M
AIRJAirJoule Technologies Corp178.24M

News

latest 14 of 200
  • Are BZH, LNTH, BGMS Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE (GlobeNewswire)
  • Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders? (PR Newswire)
  • Are GBTG, BGMS, SUNE, ESPR Obtaining Fair Deals for their Shareholders? (PR Newswire) -7.24%
  • BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. (GlobeNewswire) +41.51%
  • BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE (GlobeNewswire) -5.14%
  • BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE (GlobeNewswire)
  • Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update (GlobeNewswire) -6.94%
  • Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd. (GlobeNewswire) -5.42%
  • Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update (GlobeNewswire)
  • CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB (GlobeNewswire) -16.31%
  • CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY (GlobeNewswire) -33.50%
  • CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER (GlobeNewswire)
  • CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-14-0.040--0.0400.78--
2025Q42026-03-30-2.210--2.2080.67--
2025Q32025-11-13-1.310--1.3090.08--
2025Q22025-08-13-0.980--0.8450.01--
2025Q12025-05-150.000--0.0940.01--
2024Q42025-04-02-79.200--82.6270.01--
2024Q32024-11-12-43.200-129.6-218.230.010.011
2024Q22024-08-14-172.8-344.4-433.020.000.032
2024Q12024-05-14-544.8-1,139-544.80.030.002
2023Q42024-03-19-1,495-1,414-1,4950.030.003
2023Q32023-11-13-1,764-1,308-1,7320.020.003
2023Q22023-08-09-1,584-1,812-1,5770.370.003
2023Q12023-05-11-1,692-2,388-1,6810.000.003
2022Q42023-03-06-2,160-1,737-2,1440.000.004
2022Q32022-11-09-1,512-1,836-1,5040.000.004
2022Q22022-08-10-1,656-1,935-1,6430.000.004

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-140,400--140,4000.00-
2018FY-44,640-45,000-44,5850.150.00
2019FY-36,000-36,720-35,4270.000.00
2020FY-13,932-9,228-12,3070.000.00
2021FY-7,704-8,298-7,6980.000.00
2022FY-6,840-6,408-7,8100.000.00
2023FY-6,420-4,854-6,4190.420.26
2024FY-501.6--502.460.04-
2025FY-6.450--6.4500.75-
2026FY--268.8--0.10
2027FY-880.8--80.58
2028FY-1,318--118.08

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2025Q4S2024-12-291000.030.030.03
2025Q4S2024-12-281000.030.030.03
2025Q4S2024-12-271000.030.030.03
2025Q4S2024-12-261000.030.030.03
2025Q4S2024-12-251000.030.030.03
2025Q4S2024-12-241000.030.030.03
2025Q4S2024-12-231000.030.030.03
2025Q4S2024-12-221000.030.030.03
2025Q4S2024-12-211000.030.030.03
2025Q4S2024-12-201000.030.030.03
2025Q4S2024-12-191000.030.030.03
2025Q4S2024-12-181000.030.030.03
2025Q4S2024-12-171000.030.030.03
2025Q4S2024-12-161000.030.030.03

Estimate history

EPS, annual-140400.001-44584.56-35426.88-12306.888-7698.348-7809.66-6419.069-502.464-6.449-3.632
Period201720182019202020212022202320242025TTM
EPS, quarterly-433.015-218.232-82.627-0.094-0.845-1.309-2.208-0.04-0.076
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual00.1500000.420.0430.7471.86
Period201720182019202020212022202320242025TTM
Sales, quarterly0.0040.010000.0810.6660.7780.336
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0000.0020.0030.0030.0040.0375.46.623
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.0080.0090.0370.8641.5843.4985.45.5196.623
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1.860.750.040.420.000.000.000.000.15
Cost of Goods Sold Incl. D&A1.500.610.010.030.030.040.020.02-
Gross Profit0.360.130.040.39-0.03-0.04-0.02-0.02-
Selling, General and Administrative Excl. Other3.108.5615.7630.6930.9422.8910.629.669.67
Research and Development-0.8410.3623.9723.5515.434.744.644.30
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-2.74-8.43-15.72-30.30-30.97-22.94-10.64-9.68-9.55
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00--
Net Income Before Taxes-2.16-2.99-15.71-30.40-29.23-22.73-9.68-9.13-8.62
Income Taxes0.040.01-4.50-7.84-8.03-3.85-1.24-1.30-1.34
Consolidated Net Income-13.23-14.03-11.21-22.55-21.20-18.89-8.45-7.83-7.29
Net Income From Continuing Operations-13.23-14.03-11.21-22.55-21.20-18.89-8.45-7.83-7.29
Net Income-13.31-14.09-11.21-22.76-21.40-19.09-12.42-8.03-7.49
EPS (Recurring)-2.38-6.45-502.46-6,419.07-7,809.66-7,698.35-12,306.87-35,427.09-44,584.27
EPS (Basic, Before Extraordinaries)-3.63-6.45-502.46-6,419.07-7,809.66-7,698.35-12,306.89-35,426.88-44,584.56
EPS (Diluted)-3.63-6.45-502.46-6,419.07-7,809.66-7,698.35-12,306.89-35,426.88-44,584.56
EBITDA-2.73-8.42-15.71-30.27-30.94-22.89-10.62-9.66-9.52
Non-Operating Income (Expense)0.585.440.01-0.101.740.200.950.560.92
Other After Tax Adjustments-11.03-11.030.000.000.000.000.000.000.00
Stock Option Compensation Expense0.531.840.471.161.190.840.310.340.26
Price To Sales Ratio2.744.3346.835.41----48.78
Gross Margin19.2917.8086.0592.62-----
Operating Margin-147.13-1,128.11-36,555.81-7,214.05-----6,365.33
Net Margin-715.48-1,886.48-26,074.42-5,418.10-----4,992.67
Shares Outstanding6.625.400.040.000.000.000.000.000.00
Market Capitalization4.445.313.332.258.3638.8748.7911.527.56

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.340.780.670.080.000.000.000.01
Cost of Goods Sold Incl. D&A0.260.640.550.060.000.000.000.00
Gross Profit0.080.140.120.02-0.000.00-0.000.01
Selling, General and Administrative Excl. Other0.500.391.201.011.325.041.822.19
Research and Development--0.00-0.050.010.070.820.880.95
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.42-0.25-1.08-0.99-1.32-5.04-1.83-2.18
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-0.40-0.17-0.61-0.99-1.32-0.08-1.86-2.17
Income Taxes0.010.030.010.000.000.001.19-0.21
Consolidated Net Income-0.41-0.20-10.15-2.48-1.32-0.08-3.05-1.96
Net Income From Continuing Operations-0.41-0.20-10.15-2.48-1.32-0.08-3.05-1.96
Net Income-0.42-0.22-10.17-2.50-1.34-0.08-3.05-1.96
EPS (Recurring)-0.08-0.04-2.21-1.31-0.84-0.09-82.63-218.23
EPS (Basic, Before Extraordinaries)-0.08-0.04-2.21-1.31-0.84-0.09-82.63-218.23
EPS (Diluted)-0.08-0.04-2.21-1.31-0.84-0.09-82.63-218.23
EBITDA-0.42-0.24-1.08-0.99-1.32-5.04-1.82-2.18
Non-Operating Income (Expense)0.020.080.480.000.004.96-0.030.01
Other After Tax Adjustments0.000.00-9.54-1.490.000.000.000.00
Stock Option Compensation Expense0.000.000.520.010.011.320.070.08
Price To Sales Ratio2.743.589.13116.64784.774,134.8877.4728.79
Gross Margin23.5118.2518.1720.99---90.00
Operating Margin-124.40-31.62-162.46-1,224.69----21,770.00
Net Margin-126.49-27.89-1,527.03-3,090.12----19,570.00
Shares Outstanding6.625.525.403.501.580.860.040.01
Market Capitalization4.444.907.2511.067.8557.893.332.13

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments3.503.143.3818.3436.5633.4111.8817.5023.91
Short Term Receivables1.260.002.934.663.731.311.331.501.49
Inventories1.380.000.000.000.000.000.000.000.00
Other Current Assets0.110.541.131.400.660.750.810.780.58
Total Current Assets6.263.677.4424.4140.9435.4714.0219.7925.97
Net Property, Plant & Equipment0.150.010.100.170.091.331.290.040.03
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets1.570.000.000.000.000.000.000.000.00
Other Assets0.210.411.263.461.550.000.000.000.00
Total Assets8.194.098.8028.0542.5936.8015.3119.8226.00
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.000.00
Accounts Payable0.624.603.542.562.120.510.892.721.56
Other Current Liabilities0.711.674.624.953.181.971.531.732.56
Total Current Liabilities1.336.278.167.515.292.492.424.454.11
Long Term Debt0.000.000.040.110.031.061.190.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.010.000.000.000.000.000.000.100.12
Total Liabilities1.346.278.207.625.323.543.614.554.24
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.004.490.000.000.000.000.00
Common Equity6.84-2.170.6115.9437.2633.2611.7015.2721.77
Total Shareholders Equity6.84-2.170.6120.4337.2633.2611.7015.2721.77
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity6.84-2.170.6120.4337.2633.2611.7015.2721.77
Total Liabilities & Stockholders Equity8.194.098.8028.0542.5936.8015.3119.8226.00
Book Value Per Share1.27-58.90137.586,090.0213,423.9019,166.7048,964.2687,984.69130,623.79
Tangible Book Value Per Share0.98-58.90137.586,090.0213,423.9019,166.7048,964.2687,984.69130,623.79
Full-Time Employees------121412
Price to Book Ratio0.74-1.530.520.311.041.470.990.500.87
Return on Assets-228.54-173.84-124.25-60.02-47.58-32.41-44.58-31.81-32.72
Return on Equity-601.16--218.87-73.48-53.56-37.57-58.07-39.35-41.46
Return on Invested Capital-205.01--3,502.33-103.21-50.64-24.61-60.75-47.72-34.32
Quick Ratio3.660.590.913.257.7314.275.794.456.32
Current Ratio4.700.590.913.257.7314.275.794.456.32

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-2.22-3.00-11.21-22.55-21.20-18.89-8.45-7.83-7.29
Depreciation0.010.010.010.030.030.040.020.020.03
Other Funds (Non Cash)0.677.280.561.401.551.330.340.360.33
Funds from Operations-1.544.29-10.65-21.12-19.62-17.52-8.09-7.45-6.93
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.45-9.062.665.01-1.21-1.020.15-1.990.23
Cash from Operating Activities-1.10-4.77-7.99-16.11-20.83-18.54-7.93-9.45-6.70
Capital Expenditures-0.000.000.00-0.01-0.01-0.03-0.10-0.01-0.04
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.04-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.000.000.00-0.01-0.01-0.03-0.100.03-0.04
Cash Dividends Paid-0.06-0.060.00-0.20-0.20-0.20-0.20-0.20-0.20
Change in Capital Stock0.685.337.821.053.2021.9429.704.050.63
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.685.337.821.053.2021.9429.704.050.63
Proceedsfrom Stock Options-1.10-1.101.610.000.000.000.000.000.63
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities0.625.267.820.853.0021.7429.503.850.43
Exchange Rate Effect-0.00-0.13-0.070.30-0.38-0.020.05-0.05-0.10
Net Change in Cash-0.480.37-0.24-14.97-18.213.1521.52-5.62-6.41
Free Cash Flow-1.10-4.77-7.99-16.12-20.83-18.57-8.03-9.46-6.74
Preferred Dividends (Cash Flow)--0.060.00-0.20-0.20-0.20-0.20-0.20-0.20
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments3.793.343.503.844.283.45
Short Term Receivables1.071.191.260.720.000.00
Inventories0.970.951.381.370.000.00
Other Current Assets0.130.150.110.510.110.26
Total Current Assets5.975.626.266.444.383.71
Net Property, Plant & Equipment0.140.150.150.140.020.02
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.571.571.571.570.000.00
Other Assets0.170.220.210.000.000.00
Total Assets7.857.568.198.164.403.73
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable0.190.260.620.470.220.11
Other Current Liabilities0.500.540.710.530.540.55
Total Current Liabilities0.690.801.331.000.760.66
Long Term Debt0.000.000.000.010.010.01
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.010.010.060.000.00
Total Liabilities0.690.801.341.060.770.67
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7.166.766.847.103.633.06
Total Shareholders Equity7.166.766.847.103.633.06
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity7.166.766.847.103.633.06
Total Liabilities & Stockholders Equity7.857.568.198.164.403.73
Book Value Per Share1.081.221.272.032.293.54
Tangible Book Value Per Share0.840.940.981.582.293.54
Price to Book Ratio0.620.790.732.162.1618.91
Return on Assets-215.98-250.43-228.54-102.39-101.76-168.60
Return on Equity-245.28-288.07-601.16-226.28-276.72-1,949.77
Return on Invested Capital-5.66-2.91-148.31-34.95-36.20-2.64
Quick Ratio7.225.873.665.075.775.60
Current Ratio8.637.064.706.435.775.60

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-0.41-0.20-0.61-1.01-1.30-0.08
Depreciation0.000.000.000.000.000.00
Other Funds (Non Cash)0.00-0.000.660.024.931.68
Funds from Operations-0.41-0.200.05-0.993.641.59
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.05-0.08-0.080.56-4.69-4.84
Cash from Operating Activities-0.35-0.28-0.03-0.43-1.06-3.25
Capital Expenditures0.00-0.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.00-0.000.000.000.000.00
Cash Dividends Paid-0.02-0.02-0.020.00-0.040.00
Preferred Dividends (Cash Flow)-0.02-0.02-0.020.00--
Change in Capital Stock0.790.12-0.24-0.001.923.65
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.790.12-0.24-0.001.923.65
Proceedsfrom Stock Options0.000.00-1.100.000.25-0.25
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.770.10-0.26-0.001.883.65
Exchange Rate Effect0.030.01-0.040.000.00-0.09
Net Change in Cash0.45-0.17-0.33-0.440.820.31
Free Cash Flow-0.35-0.28-0.03-0.43-1.06-3.25

Revenue breakdown

Wholesale-Durable Goods, NEC2024: 43.00K 2025: 747.00K
Malaysia2025: 747.00K
United Kingdom2024: 43.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.56%0.0M4.9M74.67K
2026-10-150.62%0.0M4.9M76.36K
2026-09-300.12%0.0M4.9M85.63K
2026-09-151.87%0.1M4.9M117.54K
2026-08-310.72%0.0M4.9M2.25M
2026-08-141.20%0.1M4.9M2.28M
2026-07-312.08%0.1M3.2M2.28M
2026-07-153.16%0.1M3.2M2.33M
2026-06-303.19%0.1M3.2M2.32M
2026-06-156.04%0.2M3.2M2.26M
2026-05-290.91%0.0M3.5M86.09K
2026-05-150.82%0.0M3.2M85.71K
2026-04-301.14%0.0M3.2M133.24K
2026-04-151.86%0.1M3.2M122.74K
2026-03-311.08%0.0M2.2M91.16K
2026-03-131.10%0.0M1.9M81.67K
2026-02-271.19%0.0M1.9M82.59K
2026-02-131.19%0.0M1.9M90.63K
2026-01-303.40%0.1M1.9M99.47K
2026-01-153.68%0.1M1.9M310.22K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-048-KCurrent report2026-10-29SEC
2026-10-23S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-10-168-KCurrent report2026-10-16SEC
2026-10-09424B3SEC
2026-10-08EFFECTEffectiveness filing by commission orderSEC
2026-09-11S-4/ASEC
2026-08-21S-4/ASEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-148-KCurrent report2026-08-12SEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-12SCHEDULE 13G/ASEC
2026-07-24S-4/ASEC
2026-07-018-KCurrent report2026-07-01SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-06-16S-4Registration statement for securities to be issued in business combination transactionsSEC
2026-06-108-KCurrent report2026-06-10SEC
2026-06-04425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-05-1510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-05-12SCHEDULE 13G/ASEC
2026-05-01DEFR14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-27DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-27SEC
2026-04-138-KCurrent report2026-04-13SEC
2026-03-3010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-308-KCurrent report2026-03-30SEC
2026-03-13SCHEDULE 13G/ASEC
2026-03-13SCHEDULE 13G/ASEC
2026-03-138-KCurrent report2026-03-12SEC
2026-01-128-KCurrent report2026-01-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110048.52K1

Institutional holders

Manager% owned
CITADEL ADVISORS LLC1.36%
JANE STREET GROUP, LLC0.30%
Tower Research Capital LLC0.10%
SBI Securities Co., Ltd.0.01%
UBS Group AG0.00%
Root Financial Partners, LLC0.00%
BARCLAYS PLC0.00%
OSAIC HOLDINGS, INC.0.00%
Archer Investment Corp0.00%
CITIGROUP INC0.00%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.09%

OakChart. BGMS. Cached 15 minutes.

Some panels did not load: insider.